Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The aim of this Phase III study was to assess the efficacy of idebenone on pulmonary
function, motor function, muscle strength and quality of life in patients with DMD.
Furthermore, the safety and tolerability of idebenone was assessed.